Masliah E, Sisk A, Mallory M, Mucke L, Schenk D, Games D
The following sgRNAs for GCLC CRISPRCas9 KO were used: sgNTC forward: 5-CACCGGAGGCTAAGCGTCGCAA-3
Chemoimmunotherapy with a Modified Hyper-CVAD and Rituximab Regimen Improves Outcome for Patients with De Novo Philadelphia Negative Precursor B-Cell Acute Lymphoblastic Leukemia (ALL)
[PMID: 16773246] PubMed record related to this compound for laboratory literature review
We typically recommend AnyLabTestNow , and you can find a location near you at: www.anylabtestnow.com/locations Once your sample is collected, contact our office and well schedule your results appointment with Dr
Uden S, Acheson D.W.K, Reeves J, Worthington H.V, Hunt L.P, Brown S, Braganza J.M